BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37748956)

  • 21. Predictive value of Dmax and %ΔSUVmax of
    Dang J; Peng X; Wu P; Yao Y; Tan X; Ye Z; Jiang X; Jiang X; Liu Y; Chen S; Cheng Z
    BMC Med Imaging; 2023 Oct; 23(1):173. PubMed ID: 37907837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of
    Feng L; Yang S; Lin Y; Li J; Cao Z; Zheng Q; Wang H; Yang J
    Pediatr Radiol; 2024 May; 54(6):954-964. PubMed ID: 38613691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of baseline
    Xia L; Li X; Zhu J; Gao Z; Zhang J; Yang G; Wang Z
    Radiat Oncol; 2023 Feb; 18(1):41. PubMed ID: 36829219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Significance of Pretreatment FDG PET/CT in MIBG-Avid Pediatric Neuroblastoma.
    Kang SY; Rahim MK; Kim YI; Cheon GJ; Kang HJ; Shin HY; Kang KW; Chung JK; Kim EE; Lee DS
    Nucl Med Mol Imaging; 2017 Jun; 51(2):154-160. PubMed ID: 28559940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumor Heterogeneity Assessed by
    Lue KH; Wu YF; Liu SH; Hsieh TC; Chuang KS; Lin HH; Chen YH
    Acad Radiol; 2020 Aug; 27(8):e183-e192. PubMed ID: 31761665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of Intratumoral Metabolic Heterogeneity and Quantitative
    Pinho DF; King B; Xi Y; Albuquerque K; Lea J; Subramaniam RM
    AJR Am J Roentgenol; 2020 Apr; 214(4):908-916. PubMed ID: 32069078
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic Value of Baseline
    Moon SH; Choi WH; Yoo IR; Lee SJ; Paeng JC; Jeong SY; Lee SW; Kim K; Choi JY
    Korean J Radiol; 2018; 19(3):481-488. PubMed ID: 29713226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of a Machine Learning Approach for the Analysis of Clinical and Radiomic Features of Pretreatment [
    Nakajo M; Jinguji M; Tani A; Kikuno H; Hirahara D; Togami S; Kobayashi H; Yoshiura T
    Mol Imaging Biol; 2021 Oct; 23(5):756-765. PubMed ID: 33763816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [
    Dongxiang W; Liting L; Yujing L; Meijuan L; Shanshan G; Longbin X; Yanzhou C; Meiling C; Kang N; Haiqiang M; Linquan T; Qiuyan C
    Eur Radiol; 2023 Apr; 33(4):2840-2849. PubMed ID: 36422647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of
    Lim CH; Moon SH; Cho YS; Choi JY; Lee KH; Hyun SH
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1705-1712. PubMed ID: 31049603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].
    Zhang Y; Zhou J; Wang L; Li JY; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):885-890. PubMed ID: 33113633
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer].
    Ding CY; Guo Z; Li YY; Li TR
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):828-834. PubMed ID: 29151289
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on
    Liu X; Xiang K; Geng GY; Wang SC; Ni M; Zhang YF; Pan HF; Lv WF
    Contrast Media Mol Imaging; 2022; 2022():2586245. PubMed ID: 35173559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Semiquantitative parameters of
    Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of Interim 18F-DOPA and 18F-FDG PET/CT Findings in Stage 3-4 Pediatric Neuroblastoma.
    Ko KY; Yen RF; Ko CL; Chou SW; Chang HH; Yang YL; Jou ST; Hsu WM; Lu MY
    Clin Nucl Med; 2022 Jan; 47(1):21-25. PubMed ID: 34874346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nomograms based on SUVmax of
    Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
    Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Histogram-Based Textural Analysis of
    Önner H; Coşkun N; Erol M; Eren Karanis Mİ
    Mol Imaging Radionucl Ther; 2022 Feb; 31(1):33-41. PubMed ID: 35114750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
    Bang JI; Ha S; Kang SB; Lee KW; Lee HS; Kim JS; Oh HK; Lee HY; Kim SE
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Mi L; Zhao Y; Zhao X; Yin F; Yin X; Li N; Shi J; Han X; Duan X; Zhao M; Han G; Wang J
    Cancer Biother Radiopharm; 2021 Oct; 36(8):662-671. PubMed ID: 32783634
    [No Abstract]   [Full Text] [Related]  

  • 40. Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival.
    Dai N; Liu H; Deng S; Sang S; Wu Y
    Technol Cancer Res Treat; 2021; 20():15330338211056478. PubMed ID: 34806464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.